printer iconPrinter-friendly Version

FOR IMMEDIATE RELEASE: June 14, 2010

SCHUMER REVEALS: EVIDENCE MOUNTING THAT SUGGESTS POSSIBLE LINK BETWEEN CHEMICAL FOUND IN MOST SUNSCREENS AND SKIN CANCER, FDA HAS BEEN STUDYING ISSUE FOR ALMOST A YEAR; SCHUMER CALLS ON FDA TO MAKE RESULTS OF INVESTIGATION IMMEDIATELY CLEAR.


Several Studies Raise Concerns Over Potential Link Between Retinyl Palmitate (RA), A Common Sunscreen Additive, and Skin Cancer; FDA Has Been Reviewing the Data Since July 2009 But Has Yet to Provide Ruling

As Summer Gets Underway and Beach Season is Here, Schumer Urges the FDA to Act Swiftly in Their Final Assessment of the Data

Schumer: Time is of the Essence and the FDA Needs to Provide Guidance and Reassurance to Consumers

Today, U.S. Senator Charles E. Schumer called on the Food and Drug Administration (FDA) to immediately address recent reports suggesting a possible link between skin cancer and a common chemical found in sunscreens. Studies from the National Center for Toxicological Research (NCTR) and the National Toxicology Program (NTP) have suggested a possible link between skin cancer and retinyl palmitate, a common ingredient found in sunscreen products. While the research has been completed since July 2009, the FDA has yet to issue a final assessment or guidance on the data. Schumer says that considering the serious implications of the studies and the fact that consumers use sunscreen products to protect themselves from UV rays and skin cancer, consumers deserve to hear the FDA’s evaluation of the data immediately. In light of the delays, Schumer is pushing the FDA to promptly address these studies and also announce a timeline for new sunscreen regulations.
 
“With the recent reports suggesting a possible link between skin cancer and a common chemical found in sunscreens, the FDA must act now to protect consumers in New York and across the nation,” Schumer said. “Summer is here, people are soaking up the sun and the FDA needs to immediately provide guidance and reassurance to consumers. When it comes to the health and safety of the public, there is no room for delay.”
 
Retinyl palmitate is an ingredient found in most of the 500 most popular sunscreen products. Scientists at both the NCTR and the NTP have been working diligently over the last decade at the FDA’s request in order to determine whether this Vitamin A derivative, retinyl palmitate, is safe to use in sunscreen products. In one study, tumors and lesions developed up to 21 percent faster in lab animals coated in retinyl palmitate-laced cream than animals treated with a cream that did not contain RP. While these studies have been completed for almost a year now, the FDA has not issued an assessment of ruling on either of them.
 
As the summer season begins, Schumer is urging the FDA to work to make public their reviews and assessments of the data as soon as possible so as not to undermine consumer confidence in the protective value and safety of sunscreen products.
 
Schumer added, “Millions of Americans use sunscreen to keep themselves and their families protected from the dangers of too much sun. If the product they are using is doing more harm than good, they have a right to know.”

###

Resource Center
chuck around new york icon
Chuck in New York
See what Chuck has been doing in
your area lately
Casework Icon
Services for New Yorkers
For help cutting through the federal government's red tape
Tours Icon
Schedule a Tour
Plan your trip to Washington D.C.
Veterans Icon
Veterans Assistance
Help for those who have served our nation
Protecting Consumers icon
Protecting Consumers
Help and Resources for New York consumers
Grants Assistance icon
Grants Assistance
Guide to applying for federal grants
Financial aid assistance icon
Financial Aid Assistance
Guide to applying for federal financial aid
e-newsletter icon
facebook icon
twitter icon
youtube icon
flickr icon
CMF Bronze Mouse Award for the 111th Congress